by Rawamino | Oct 22, 2025 | Peptides
Introduction Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline, memory impairment, and neuronal loss. While the accumulation of amyloid beta (Aβ) plaques remains one of the most widely studied features of...
by Rawamino | Oct 22, 2025 | Peptides
Introduction GHK-Cu (glycyl-L-histidyl-L-lysine–copper) is a small, copper-binding tripeptide that was first described in human plasma and later detected across multiple tissues. Early observations suggested that endogenous levels may decline with age, prompting...
by Rawamino | Oct 21, 2025 | Peptides
Introduction In recent years, peptides have become a focal point in hair growth research due to their capacity to influence signaling pathways that regulate vascularization, inflammation, and cellular turnover. Earlier studies offered only fragmentary insights into...
by Rawamino | Oct 21, 2025 | Peptides
Introduction Growth hormone (GH) biology appears to rely on coordinated inputs from hypothalamic, pituitary, and peripheral pathways that together shape pulsatility, downstream insulin-like growth factor-1 (IGF-1) production, and tissue remodeling. Within this...
by Rawamino | Oct 21, 2025 | Peptides
Introduction The “hallmarks of aging” framework proposes that age-associated decline may arise from interconnected biological processes that progressively impair cellular resilience. Originally synthesized in 2013 and refined in subsequent years, this model now...
by Rawamino | Oct 21, 2025 | Peptides
Introduction Sleep appears to be orchestrated by interacting neural circuits, endocrine cues, and cellular homeostasis programs that together shape architecture across non-REM and REM stages. Disruptions in these processes have been associated with impaired cognition,...
